MarkNtel Advisors recently published a report on the global 2020-2025). It reveals the major factors that define the industry’s current inclinations and options, as well as its business strategies in the coming years. The research includes an overview of revenue, sales, cost, and growth projections for the year 2025. Furthermore, statistical data regarding CAGR of around 11% during 2020-25F,covered leading market players, segments, and regions is also covered in the report.
Owing to the factors such as escalating investment by the major pharmaceutical companies in precision medicine, increasing burden of cancer cases, and booming ageing population worldwide. Moreover, technological advancement in wireless technologies and big data analytics, the rising patient inclination toward personalized treatment, and significant strides in the research areas pertaining to precision medicine in the recent years are some of the factors expected to fuel the growth of the market in the coming years. Moreover, COVID-19 has a positive impact on the Global precison medicine market as it is widely use to accelerate the COVID-19 treatment.
What Information does this Precision Medicine Market Report contain?
-Growth Projections of Precision Medicine Market : 2020-2025.
-Expert Analysis: industry trends, innovation and technological trends, factors affecting development,
-SWOT analysis, PESTLE analysis.
-Competitive landscape reporting: major market leaders, competencies and capacities of these players in terms of production and sustainability, major strategies adopted by them.
The report provides following information about the major market players of Precision Medicine Industry:
-Key Product/Service Offerings
-Porter’s Five Forces Model
-Key Performance Indicators
Market players covered in this report with all the above-mentioned information are Orion Health, 2B Precise, Fabric Genomics, Pfizer, Gene 42, IBM Watson Health, Philips Healthcare, Medtronic, Nanthealth, Navican, N-of-One, PierianDx, Sunquest Information System, Tempus, Novartis, Translational Software, Biocrates Life Sciences AG, anostring Technologies, Thermo Fisher Scientific, Quest Diagnostics Incorporated etc.
This section of the study includes data on different Precision Medicine Market segments at the national and regional levels. For the Precision Medicine Market , it gives detailed and comprehensive market segment analysis. The market is classified into following segments:
-Whole Genome Sequencing
-Big data analytics
-Central Nervous System (CNS)
-Pharmaceutical and Biotechnology Companies
-Healthcare IT Companies
-Middle East & Africa
Key Points of Precision Medicine Market Report:
-Offers strategies for organizations to deal with the impact of COVID-19.
-Presents external environment analysis of the market and PEST analysis.
-Provide details regarding market dynamic analysis, including market growth factors, market development constraints, opportunities and threats.
-Analyzes the market opportunities for stakeholders and provides market leaders with crucial details of the competitive landscape.
-Detailed overview of market entry strategy analysis for new entrants or players who are keen to enter the market, including market segment definition, distribution model, product positioning, and price strategy analysis.
-Tracking and keeping up with the international market trends and providing analysis of the impact of the COVID-19 pandemic.
MarkNtel Advisors is a leading research, consulting and data analytics firm that provides a wide range of strategic reports on diverse industry verticals to a substantial and varied client base that includes multinational corporations, financial institutions, governments, and individuals.
We specialize in niche industries and emerging geographies to support our clients in the formulation of strategies viz. Go to Market (GTM), product development, feasibility analysis, project scoping, market segmentation, competitive benchmarking, market sizing & forecasting, trend analysis, etc. in around 15 industry verticals to enable our clients in identifying attractive investment opportunities and maximizing ROI through an early mover advantage.